Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Receivables (2016 - 2026)

Healthstream has reported Receivables over the past 16 years, most recently at $39.0 million for Q4 2025.

  • Quarterly Receivables rose 10.41% to $39.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.0 million through Dec 2025, up 10.41% year-over-year, with the annual reading at $39.0 million for FY2025, 10.41% up from the prior year.
  • Receivables was $39.0 million for Q4 2025 at Healthstream, up from $33.7 million in the prior quarter.
  • Over five years, Receivables peaked at $47.3 million in Q1 2023 and troughed at $30.7 million in Q3 2021.
  • The 5-year median for Receivables is $35.7 million (2024), against an average of $36.8 million.
  • Year-over-year, Receivables dropped 24.25% in 2021 and then rose 22.31% in 2022.
  • A 5-year view of Receivables shows it stood at $34.9 million in 2021, then increased by 22.31% to $42.7 million in 2022, then fell by 9.98% to $38.4 million in 2023, then dropped by 8.13% to $35.3 million in 2024, then rose by 10.41% to $39.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Receivables are $39.0 million (Q4 2025), $33.7 million (Q3 2025), and $31.5 million (Q2 2025).